Literature DB >> 24342512

Simultaneous determination of imperatorin and its metabolite xanthotoxol in rat plasma by using HPLC-ESI-MS coupled with hollow fiber liquid phase microextraction.

Juan Zhang1, Min Zhang2, Shan Fu1, Tao Li1, Shuang Wang1, Minmin Zhao1, Weijing Ding1, Chunying Wang1, Qiao Wang3.   

Abstract

The objective of the present study was to develop a new method for the simultaneous quantitation of imperatorin and its metabolite xanthotoxol in rat plasma. The samples were prepared with hollow fiber liquid phase microextraction (HF-LPME). The optimized extraction procedure was acquired by assessing extraction solvent, length of the fiber, agitation rate, extraction temperature and time. A comparison of sample pretreatment ways between HF-LPME and deproteinization with methanol was performed, which demonstrated less ion suppression and better sensitivity of HF-LPME. Analytes were separated on a C18 column with a gradient elution consisted of methanol and water containing 1mmol/L ammonium acetate. The detection was accomplished by electrospray ionization (ESI) source operating in the positive ionization mode. Selected-multiple-reaction monitoring (SMRM) scanning was employed, which guaranteed a higher sensitivity compared with MRM mode. Calibration curves were linear over investigated ranges with correlation coefficients greater than 0.9979. Precision varied from 0.26% to 14%, and the accuracy varied within ±5.5%. The developed method was successfully applied to the pharmacokinetic research of imperatorin and its metabolite xanthotoxol after oral administration of imperatorin to rats.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HPLC–ESI-MS; Hollow fiber liquid phase microextraction; Imperatorin; Pharmacokinetics; Xanthotoxol

Mesh:

Substances:

Year:  2013        PMID: 24342512     DOI: 10.1016/j.jchromb.2013.11.050

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  3 in total

1.  Imperatorin as a Promising Chemotherapeutic Agent Against Human Larynx Cancer and Rhabdomyosarcoma Cells.

Authors:  Aneta Grabarska; Krystyna Skalicka-Woźniak; Michał Kiełbus; Magdalena Dmoszyńska-Graniczka; Paulina Miziak; Justyna Szumiło; Ewa Nowosadzka; Krystyna Kowalczuk; Sherief Khalifa; Jolanta Smok-Kalwat; Janusz Klatka; Krzysztof Kupisz; Krzysztof Polberg; Adolfo Rivero-Müller; Andrzej Stepulak
Journal:  Molecules       Date:  2020-04-28       Impact factor: 4.411

2.  Pharmacokinetics and Brain Distribution of the Active Components of DA-9805, Saikosaponin A, Paeonol, and Imperatorin in Rats.

Authors:  Mi Hye Kwon; Jin Seok Jeong; Jayoung Ryu; Young Woong Cho; Hee Eun Kang
Journal:  Pharmaceutics       Date:  2018-08-20       Impact factor: 6.321

3.  Simultaneous Determination of Three Furanocoumarins by UPLC/MS/MS: Application to Pharmacokinetic Study of Angelica dahurica Radix after Oral Administration to Normal and Experimental Colitis-Induced Rats.

Authors:  Youn-Hwan Hwang; Hye Jin Yang; Jin Yeul Ma
Journal:  Molecules       Date:  2017-03-07       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.